Annual Meeting Supporter
Name
Charles River
What We Do
Charles River transforms drug development with 75+ years of toxicology expertise, spanning Lead Optimization to GLP/Non-GLP studies across all major therapeutic areas. With over 130 sites in 20 countries, we drive innovation through integrated toxicology solutions and groundbreaking initiatives aimed at reducing animal use. By pioneering New Approach Methodologies (NAMs) through in vitro assays, in silico modeling, and organ-on-a-chip technologies alongside Virtual Control Groups (VCGs), we blend traditional science with machine learning to deliver transformative alternatives while upholding scientific rigor and patient safety.
Apollo™, our industry-leading platform, provides real-time access to study data, enabling faster decisions, advanced visualization, and self-serve analytics. At Charles River, we deliver the precision, efficiency, and confidence required to accelerate life-saving therapies because every moment matters.
Apollo™, our industry-leading platform, provides real-time access to study data, enabling faster decisions, advanced visualization, and self-serve analytics. At Charles River, we deliver the precision, efficiency, and confidence required to accelerate life-saving therapies because every moment matters.
Website
Product or Service Categories (15)
Acute Toxicology, Agrochemical Product Safety/Toxicology, Chemical Toxicology, Chronic Toxicology, Developmental Toxicology, Genotoxicity, Ophthalmic Toxicology, Pathology, Reproductive Toxicology, Respiratory Toxicology, CRO—Contract Research Organization, GLP—Good Laboratory Practice Services, Bioanalytical Services, Biomarkers
Annual Meeting Supporter
Diamond Level